RNU7-13P

Across TCGA pan-cancer cohorts, RNU7-13P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU7-13P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU7-13P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-13P expression acts as an unfavorable survival marker, although some lineages such as BRCA and KIRC show a favorable association.

MESO, BRCA, and LUSC are the cancer types where RNU7-13P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.195	0.579	<.001	117	view →
BRCA	DFS	Tertile	III,IV	0.929	0.755	.004	58	view →
LUSC	DFS	Tertile	II,III,IV	0.342	0.752	<.001	30	view →
BLCA	OS	Tertile	III,IV	0.292	0.599	.011	18	view →
LUAD	DFS	Tertile	IV	0.140	0.603	.021	18	view →
OV	OS	Tertile	IV	0.251	0.641	.010	18	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	18	view →
KIRC	DFS	Tertile	II,III,IV	0.956	0.716	.045	12	view →
DLBC	OS	Tertile	IV	0.643	0.943	.045	9	view →
UVM	OS	Tertile	III,IV	0.104	0.808	.015	9	view →
LGG	OS	Tertile	All	0.214	0.531	.009	6	view →
THCA	OS	Tertile	IV	0.520	0.838	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU7-13P–MESO (OS)

Open the MESO breakdown →